Loading…

Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies

Background To review the available evidence from prospective studies on the safety and tolerability of the ketogenic diet (KD) for the treatment of refractory childhood epilepsy. Methods A comprehensive bibliographic search was performed with the aim of retrieving prospective studies that monitored...

Full description

Saved in:
Bibliographic Details
Published in:World journal of pediatrics : WJP 2017-12, Vol.13 (6), p.528-536
Main Authors: Cai, Qian-Yun, Zhou, Zhong-Jie, Luo, Rong, Gan, Jing, Li, Shi-Ping, Mu, De-Zhi, Wan, Chao-Min
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-c42fc432c0fbfb15b63585a110a5f04069ada990cb6a2e62c63937b31718c4903
cites cdi_FETCH-LOGICAL-c442t-c42fc432c0fbfb15b63585a110a5f04069ada990cb6a2e62c63937b31718c4903
container_end_page 536
container_issue 6
container_start_page 528
container_title World journal of pediatrics : WJP
container_volume 13
creator Cai, Qian-Yun
Zhou, Zhong-Jie
Luo, Rong
Gan, Jing
Li, Shi-Ping
Mu, De-Zhi
Wan, Chao-Min
description Background To review the available evidence from prospective studies on the safety and tolerability of the ketogenic diet (KD) for the treatment of refractory childhood epilepsy. Methods A comprehensive bibliographic search was performed with the aim of retrieving prospective studies that monitored adverse effects (AEs) in children after receiving the classic or medium-chain triglyceride KD therapy for refractory epilepsy. Results A total of 45 studies were retrieved, including 7 randomized controlled trials. More than 40 categories of AEs were reported. The most common AEs included gastrointestinal disturbances (40.6%), hyperlipidemia (12.8%), hyperuricemia (4.4%), lethargy (4.1%), infectious diseases (3.8%) and hypoproteinemia (3.8%). Severe AEs, such as respiratory failure and pancreatitis, occurred in no more than 0.5% of children. Specifically, patients receiving KD therapy should be monitored for osteopenia, urological stones, right ventricular diastolic dysfunction, and growth disturbance. The total retention rates of the diet for 1 year and 2 years were 45.7% and 29.2%, respectively. Nearly half of the patients discontinued the diet because of lack of efficacy. AEs were not the main reason for the KD discontinuation. None of the 24 deaths reported after initiation of the diet was attributed to the KD. Conclusions KD is a relatively safe dietary therapy. However, because the KD can cause various AEs, it should be implemented under careful medical supervision. Continuous follow-up is needed to address the long-term impact of the diet on the overall health of children.
doi_str_mv 10.1007/s12519-017-0053-2
format article
fullrecord <record><control><sourceid>wanfang_jour_cross</sourceid><recordid>TN_cdi_wanfang_journals_ssekzz201706002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><wanfj_id>ssekzz201706002</wanfj_id><sourcerecordid>ssekzz201706002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-c42fc432c0fbfb15b63585a110a5f04069ada990cb6a2e62c63937b31718c4903</originalsourceid><addsrcrecordid>eNp1kc1OxCAUhRujib8P4I6dq-qFtrR1Zyb-JZO4UNeE0ssMY6c0wIzpvIovK3VMXLkBLpzvXOAkySWFawpQ3njKClqnQMsUoMhSdpCc0IrHilflYVyXUKVVwevj5NT7FQBnlMNJ8vUqNYaRyL4lwXboZGM6EzesJmGJ5AODXWBvFGkNBrLx2BJt3c9ZcCjDGvswiR1qJ1WwbiRqabp2aW1LcDAdDn68JZL40QdcyxCtHG4Nfk7UsGk645fRdHDWD6iC2SLxYRO7-fPkSMvO48XvfJa8P9y_zZ7S-cvj8-xunqo8ZyGOTKs8Ywp0oxtaNDwrqkJSCrLQkAOvZSvrGlTDJUPOFM_qrGwyWtJK5TVkZ8nV3vdT9lr2C7GyG9fHjsJ7_NjtWPxV4AAsKuleqeJtfXyyGJxZSzcKCmLKQexzEJEQUw5iYtie8VHbL9D92f8PfQPnQY6p</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies</title><source>Springer Nature</source><creator>Cai, Qian-Yun ; Zhou, Zhong-Jie ; Luo, Rong ; Gan, Jing ; Li, Shi-Ping ; Mu, De-Zhi ; Wan, Chao-Min</creator><creatorcontrib>Cai, Qian-Yun ; Zhou, Zhong-Jie ; Luo, Rong ; Gan, Jing ; Li, Shi-Ping ; Mu, De-Zhi ; Wan, Chao-Min</creatorcontrib><description>Background To review the available evidence from prospective studies on the safety and tolerability of the ketogenic diet (KD) for the treatment of refractory childhood epilepsy. Methods A comprehensive bibliographic search was performed with the aim of retrieving prospective studies that monitored adverse effects (AEs) in children after receiving the classic or medium-chain triglyceride KD therapy for refractory epilepsy. Results A total of 45 studies were retrieved, including 7 randomized controlled trials. More than 40 categories of AEs were reported. The most common AEs included gastrointestinal disturbances (40.6%), hyperlipidemia (12.8%), hyperuricemia (4.4%), lethargy (4.1%), infectious diseases (3.8%) and hypoproteinemia (3.8%). Severe AEs, such as respiratory failure and pancreatitis, occurred in no more than 0.5% of children. Specifically, patients receiving KD therapy should be monitored for osteopenia, urological stones, right ventricular diastolic dysfunction, and growth disturbance. The total retention rates of the diet for 1 year and 2 years were 45.7% and 29.2%, respectively. Nearly half of the patients discontinued the diet because of lack of efficacy. AEs were not the main reason for the KD discontinuation. None of the 24 deaths reported after initiation of the diet was attributed to the KD. Conclusions KD is a relatively safe dietary therapy. However, because the KD can cause various AEs, it should be implemented under careful medical supervision. Continuous follow-up is needed to address the long-term impact of the diet on the overall health of children.</description><identifier>ISSN: 1708-8569</identifier><identifier>EISSN: 1867-0687</identifier><identifier>DOI: 10.1007/s12519-017-0053-2</identifier><language>eng</language><publisher>Hangzhou: Childrens Hospital, Zhejiang University School of Medicine</publisher><subject>Critical Care Medicine ; Imaging ; Intensive ; Maternal and Child Health ; Medicine ; Medicine &amp; Public Health ; Pediatric Surgery ; Pediatrics ; Radiology ; Review Article ; Surgery</subject><ispartof>World journal of pediatrics : WJP, 2017-12, Vol.13 (6), p.528-536</ispartof><rights>Children's Hospital, Zhejiang University School of Medicine and Springer-Verlag GmbH Germany 2017</rights><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-c42fc432c0fbfb15b63585a110a5f04069ada990cb6a2e62c63937b31718c4903</citedby><cites>FETCH-LOGICAL-c442t-c42fc432c0fbfb15b63585a110a5f04069ada990cb6a2e62c63937b31718c4903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/ssekzz/ssekzz.jpg</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Cai, Qian-Yun</creatorcontrib><creatorcontrib>Zhou, Zhong-Jie</creatorcontrib><creatorcontrib>Luo, Rong</creatorcontrib><creatorcontrib>Gan, Jing</creatorcontrib><creatorcontrib>Li, Shi-Ping</creatorcontrib><creatorcontrib>Mu, De-Zhi</creatorcontrib><creatorcontrib>Wan, Chao-Min</creatorcontrib><title>Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies</title><title>World journal of pediatrics : WJP</title><addtitle>World J Pediatr</addtitle><description>Background To review the available evidence from prospective studies on the safety and tolerability of the ketogenic diet (KD) for the treatment of refractory childhood epilepsy. Methods A comprehensive bibliographic search was performed with the aim of retrieving prospective studies that monitored adverse effects (AEs) in children after receiving the classic or medium-chain triglyceride KD therapy for refractory epilepsy. Results A total of 45 studies were retrieved, including 7 randomized controlled trials. More than 40 categories of AEs were reported. The most common AEs included gastrointestinal disturbances (40.6%), hyperlipidemia (12.8%), hyperuricemia (4.4%), lethargy (4.1%), infectious diseases (3.8%) and hypoproteinemia (3.8%). Severe AEs, such as respiratory failure and pancreatitis, occurred in no more than 0.5% of children. Specifically, patients receiving KD therapy should be monitored for osteopenia, urological stones, right ventricular diastolic dysfunction, and growth disturbance. The total retention rates of the diet for 1 year and 2 years were 45.7% and 29.2%, respectively. Nearly half of the patients discontinued the diet because of lack of efficacy. AEs were not the main reason for the KD discontinuation. None of the 24 deaths reported after initiation of the diet was attributed to the KD. Conclusions KD is a relatively safe dietary therapy. However, because the KD can cause various AEs, it should be implemented under careful medical supervision. Continuous follow-up is needed to address the long-term impact of the diet on the overall health of children.</description><subject>Critical Care Medicine</subject><subject>Imaging</subject><subject>Intensive</subject><subject>Maternal and Child Health</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Pediatric Surgery</subject><subject>Pediatrics</subject><subject>Radiology</subject><subject>Review Article</subject><subject>Surgery</subject><issn>1708-8569</issn><issn>1867-0687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kc1OxCAUhRujib8P4I6dq-qFtrR1Zyb-JZO4UNeE0ssMY6c0wIzpvIovK3VMXLkBLpzvXOAkySWFawpQ3njKClqnQMsUoMhSdpCc0IrHilflYVyXUKVVwevj5NT7FQBnlMNJ8vUqNYaRyL4lwXboZGM6EzesJmGJ5AODXWBvFGkNBrLx2BJt3c9ZcCjDGvswiR1qJ1WwbiRqabp2aW1LcDAdDn68JZL40QdcyxCtHG4Nfk7UsGk645fRdHDWD6iC2SLxYRO7-fPkSMvO48XvfJa8P9y_zZ7S-cvj8-xunqo8ZyGOTKs8Ywp0oxtaNDwrqkJSCrLQkAOvZSvrGlTDJUPOFM_qrGwyWtJK5TVkZ8nV3vdT9lr2C7GyG9fHjsJ7_NjtWPxV4AAsKuleqeJtfXyyGJxZSzcKCmLKQexzEJEQUw5iYtie8VHbL9D92f8PfQPnQY6p</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Cai, Qian-Yun</creator><creator>Zhou, Zhong-Jie</creator><creator>Luo, Rong</creator><creator>Gan, Jing</creator><creator>Li, Shi-Ping</creator><creator>Mu, De-Zhi</creator><creator>Wan, Chao-Min</creator><general>Childrens Hospital, Zhejiang University School of Medicine</general><general>Key Laboratory of Obstetric &amp; Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Sichuan University, Chengdu, China%Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, China%Key Laboratory of Obstetric &amp; Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Sichuan University, Chengdu, China</general><general>Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China</general><scope>AAYXX</scope><scope>CITATION</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>20171201</creationdate><title>Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies</title><author>Cai, Qian-Yun ; Zhou, Zhong-Jie ; Luo, Rong ; Gan, Jing ; Li, Shi-Ping ; Mu, De-Zhi ; Wan, Chao-Min</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-c42fc432c0fbfb15b63585a110a5f04069ada990cb6a2e62c63937b31718c4903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Critical Care Medicine</topic><topic>Imaging</topic><topic>Intensive</topic><topic>Maternal and Child Health</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Pediatric Surgery</topic><topic>Pediatrics</topic><topic>Radiology</topic><topic>Review Article</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cai, Qian-Yun</creatorcontrib><creatorcontrib>Zhou, Zhong-Jie</creatorcontrib><creatorcontrib>Luo, Rong</creatorcontrib><creatorcontrib>Gan, Jing</creatorcontrib><creatorcontrib>Li, Shi-Ping</creatorcontrib><creatorcontrib>Mu, De-Zhi</creatorcontrib><creatorcontrib>Wan, Chao-Min</creatorcontrib><collection>CrossRef</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>World journal of pediatrics : WJP</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cai, Qian-Yun</au><au>Zhou, Zhong-Jie</au><au>Luo, Rong</au><au>Gan, Jing</au><au>Li, Shi-Ping</au><au>Mu, De-Zhi</au><au>Wan, Chao-Min</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies</atitle><jtitle>World journal of pediatrics : WJP</jtitle><stitle>World J Pediatr</stitle><date>2017-12-01</date><risdate>2017</risdate><volume>13</volume><issue>6</issue><spage>528</spage><epage>536</epage><pages>528-536</pages><issn>1708-8569</issn><eissn>1867-0687</eissn><abstract>Background To review the available evidence from prospective studies on the safety and tolerability of the ketogenic diet (KD) for the treatment of refractory childhood epilepsy. Methods A comprehensive bibliographic search was performed with the aim of retrieving prospective studies that monitored adverse effects (AEs) in children after receiving the classic or medium-chain triglyceride KD therapy for refractory epilepsy. Results A total of 45 studies were retrieved, including 7 randomized controlled trials. More than 40 categories of AEs were reported. The most common AEs included gastrointestinal disturbances (40.6%), hyperlipidemia (12.8%), hyperuricemia (4.4%), lethargy (4.1%), infectious diseases (3.8%) and hypoproteinemia (3.8%). Severe AEs, such as respiratory failure and pancreatitis, occurred in no more than 0.5% of children. Specifically, patients receiving KD therapy should be monitored for osteopenia, urological stones, right ventricular diastolic dysfunction, and growth disturbance. The total retention rates of the diet for 1 year and 2 years were 45.7% and 29.2%, respectively. Nearly half of the patients discontinued the diet because of lack of efficacy. AEs were not the main reason for the KD discontinuation. None of the 24 deaths reported after initiation of the diet was attributed to the KD. Conclusions KD is a relatively safe dietary therapy. However, because the KD can cause various AEs, it should be implemented under careful medical supervision. Continuous follow-up is needed to address the long-term impact of the diet on the overall health of children.</abstract><cop>Hangzhou</cop><pub>Childrens Hospital, Zhejiang University School of Medicine</pub><doi>10.1007/s12519-017-0053-2</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1708-8569
ispartof World journal of pediatrics : WJP, 2017-12, Vol.13 (6), p.528-536
issn 1708-8569
1867-0687
language eng
recordid cdi_wanfang_journals_ssekzz201706002
source Springer Nature
subjects Critical Care Medicine
Imaging
Intensive
Maternal and Child Health
Medicine
Medicine & Public Health
Pediatric Surgery
Pediatrics
Radiology
Review Article
Surgery
title Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A46%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20and%20tolerability%20of%20the%20ketogenic%20diet%20used%20for%20the%20treatment%20of%20refractory%20childhood%20epilepsy:%20a%20systematic%20review%20of%20published%20prospective%20studies&rft.jtitle=World%20journal%20of%20pediatrics%20:%20WJP&rft.au=Cai,%20Qian-Yun&rft.date=2017-12-01&rft.volume=13&rft.issue=6&rft.spage=528&rft.epage=536&rft.pages=528-536&rft.issn=1708-8569&rft.eissn=1867-0687&rft_id=info:doi/10.1007/s12519-017-0053-2&rft_dat=%3Cwanfang_jour_cross%3Essekzz201706002%3C/wanfang_jour_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-c42fc432c0fbfb15b63585a110a5f04069ada990cb6a2e62c63937b31718c4903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_wanfj_id=ssekzz201706002&rfr_iscdi=true